Concepedia

A. Hagemeijer

AH

Statistics

Publications

6

Citations

368

H-Index

6

Active since

1988

Affiliations

Erasmus University Rotterdam(Current)

A. Hagemeijer is an author at Erasmus University Rotterdam specializing in hematologic malignancies, cytogenetics, and life sciences.

Publications per year

1988–2000

6

Publications

6

The clinical significance of karyotype in acute myelogenous leukemia

D Arthur, Roland Berger, Harvey M. Golomb et al. · Cancer Genetics and Cytogenetics · 1989 · 172 citations

Life Sciences, Genetics, Hematology +14

Cytogenetic studies of 103 patients with acute myelogenous leukemia in relapse

O. Margaret Garson, A. Hagemeijer, M Sakurai et al. · Cancer Genetics and Cytogenetics · 1989 · 66 citations

Medicine, Hematology, Oncology +13

High expression of the multidrug resistance P-glycoprotein in high-risk myelodysplasia is associated with immature phenotype.

Pieter Sonneveld, Jacques J. M. van Dongen, A. Hagemeijer et al. · PubMed · 1993 · 53 citations

Medicine, Cancer Biology, Pharmacology +10

Characterization of acute promyelocytic leukemia cases lacking the classic t(15;17): results of the European Working Party. Groupe Francais de Cytogenetique Hematologique, Groupe de Francais d'Hematologie Cellulaire, UK Cancer Cytogenetics Group and BIOMED 1 European Community-Concerted Action "Molecular Cytogenetic Diagnosis in Haematological Malignancies"

David Grimwade, Antonio Biondi, A. Hagemeijer et al. · HAL (Le Centre pour la Communication Scientifique Directe) · 2000 · 39 citations

Medicine, Hematology, Oncology +17

Translocation (6;9) may be associated with a specific TdT-positive immunological phenotype in ANLL.

H. J. Adriaansen, Jacques J. M. van Dongen, Herbert Hooijkaas et al. · PubMed · 1988 · 28 citations

Life Sciences, Genetics, Immunology +12

1–5 of 6